1. Home
  2. RTO vs DVA Comparison

RTO vs DVA Comparison

Compare RTO & DVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RTO
  • DVA
  • Stock Information
  • Founded
  • RTO 1925
  • DVA 1994
  • Country
  • RTO United Kingdom
  • DVA United States
  • Employees
  • RTO N/A
  • DVA N/A
  • Industry
  • RTO Business Services
  • DVA Misc Health and Biotechnology Services
  • Sector
  • RTO Consumer Discretionary
  • DVA Health Care
  • Exchange
  • RTO Nasdaq
  • DVA Nasdaq
  • Market Cap
  • RTO 12.2B
  • DVA 12.6B
  • IPO Year
  • RTO N/A
  • DVA 1995
  • Fundamental
  • Price
  • RTO $22.90
  • DVA $150.21
  • Analyst Decision
  • RTO Hold
  • DVA Hold
  • Analyst Count
  • RTO 1
  • DVA 4
  • Target Price
  • RTO N/A
  • DVA $159.75
  • AVG Volume (30 Days)
  • RTO 1.1M
  • DVA 919.3K
  • Earning Date
  • RTO 03-26-2025
  • DVA 05-01-2025
  • Dividend Yield
  • RTO 2.33%
  • DVA N/A
  • EPS Growth
  • RTO N/A
  • DVA 44.61
  • EPS
  • RTO 0.15
  • DVA 10.73
  • Revenue
  • RTO $6,805,463,398.00
  • DVA $12,815,550,000.00
  • Revenue This Year
  • RTO $6.81
  • DVA $5.62
  • Revenue Next Year
  • RTO $3.82
  • DVA $3.69
  • P/E Ratio
  • RTO $30.10
  • DVA $14.02
  • Revenue Growth
  • RTO 1.14
  • DVA 5.56
  • 52 Week Low
  • RTO $20.60
  • DVA $125.64
  • 52 Week High
  • RTO $34.07
  • DVA $179.60
  • Technical
  • Relative Strength Index (RSI)
  • RTO 46.71
  • DVA 49.62
  • Support Level
  • RTO $21.76
  • DVA $147.19
  • Resistance Level
  • RTO $23.42
  • DVA $153.42
  • Average True Range (ATR)
  • RTO 0.41
  • DVA 3.76
  • MACD
  • RTO 0.19
  • DVA 1.26
  • Stochastic Oscillator
  • RTO 81.56
  • DVA 75.60

About RTO Rentokil Initial plc

Rentokil Initial is the largest global provider of route-based pest-control and commercial hygiene services, operating in 83 countries. The group also offers a range of specialist route-based services including office and commercial space plant care, property care, and workwear rentals. The group has a diverse client base that includes global food producers, hotel chains, industrial goods businesses, restaurants, and individual residential customers.

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

Share on Social Networks: